Prognostic factors for invasive aspergillosis in patients with haematological malignancies

References

• Dasanu CA. Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice. Expert Opin Pharmacother 2008; 9: 1481–94
   PubMed Web of Science ®Google Scholar
• Nosari A, Oreste P, Cairoli R, Montillo M, Carrafiello G, Astolfi A, et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001; 68: 231–6
   PubMed Web of Science ®Google Scholar
• Schuler U, Ehninger G. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients. Bone Marrow Transplant 1994; 14(Suppl 4)S61–5
   PubMedGoogle Scholar
• Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–60
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–15
   PubMed Web of Science ®Google Scholar
• Metcalf SC, Dockrell DH. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromized hosts. J Infect 2007; 55: 287–99
   PubMed Web of Science ®Google Scholar
• Morrison VA, Haake RJ, Weisdorf DJ. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med 1994; 96: 497–503
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromized patients with cancer and haematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
   PubMed Web of Science ®Google Scholar
• Denning DW, Marinus A, Cohen J, Spence D, Herbrecht R, Pagano L, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998; 37: 173–80
   PubMed Web of Science ®Google Scholar
• Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following haematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531–40
   PubMed Web of Science ®Google Scholar
• Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253–9
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–15
   PubMed Web of Science ®Google Scholar
• Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the post-mortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23–32
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383–96
   PubMed Web of Science ®Google Scholar
• Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139–47
   PubMed Web of Science ®Google Scholar
• Hauggaard A, Ellis M, Ekelund L. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Acta Radiol 2002; 43: 292–8
   PubMed Web of Science ®Google Scholar
• Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, de Bacquer D, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26: 1098–103
   PubMed Web of Science ®Google Scholar
• Kaiser L, Huguenin T, Lew PD, Chapuis B, Pittet D. Invasive aspergillosis: clinical features of 35 proven cases at a single institution. Medicine (Baltimore) 1998; 77: 188–94
   PubMedGoogle Scholar
• Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and non-neutropenic patients: a 6-y survey. Clin Infect Dis 2006; 43: 577–84
   PubMed Web of Science ®Google Scholar
• Girmenia C, Pizzarelli G, Pozzi E, Cimino G, Gentile G, Martino P. Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with haematological malignancies or aplastic anaemia: the role of voriconazole. Haematologica 2008; 93: 159–60
   PubMedGoogle Scholar
• Baddley, JW. 42nd Annual Meeting of the IDSA 174. 2004.
   Google Scholar
• Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563–71
   PubMed Web of Science ®Google Scholar
• Ribaud P, Chastang C, Latge JP, Baffroy-Lafitte L, Parquet N, Devergie A, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322–30
   PubMed Web of Science ®Google Scholar
• Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348–59
   PubMed Web of Science ®Google Scholar
• Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335–47
   PubMed Web of Science ®Google Scholar